Firefly Aerospace Inc. rated Strong Buy with a $50 target, citing a $1.3B AST SpaceMobile deal and a path to positive ...

Honoring the profound legacies of Black luminaries we lost in 2026—trailblazers whose voices, art, and activism continue to ...

A systematic review and meta-analysis reveals that health facilities in conflict-affected African countries maintain an ...

Corvus Pharmaceuticals is funded into Q2 2028, with major readouts expected within this runway, reducing near-term financing ...

<?xml encoding="utf-8" ?> Alcon ALC reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is ...

Focus development efforts on tagmokitug/toripalimab as a potential best-in-disease treatment for esophageal cancer with plans ...

In a 26-week home exercise trial involving older adults, researchers found that baseline psychological differences in ...

C++ is a programming language that excels in processing speed and hardware control, and it has been used for many years in ...

Videos, high-quality visual images, and immersive 3D content occupy the dominant, largest share of modern digital media ...

A 3-line summary of this article Even if two numbers move together, it does not necessarily mean one is moving the other.

NEWARK, CA / ACCESS Newswire / November 5, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the third quarter ended September 30, ...

Novo recently presented post hoc analyses of its Phase 2 coramitug trial at the HFSA Annual Scientific Meeting. At week 52, the pooled coramitug dose groups (10 and 60 mg/kg) reported an ~8% decrease ...